Jaguar Health
JAGX
14 hedge funds and large institutions have $191K invested in Jaguar Health in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, reducing their positions, and 0 closing their positions.
75% more funds holding
Funds holding: 8 → 14 (+6)
25% more capital invested
Capital invested by funds: $153K → $191K (+$38.2K)
0% less ownership
Funds ownership: 0% → 0% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$54.7K |
| 2 |
VF
Virtu Financial
New York
|
+$27.4K |
| 3 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$13.7K |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$13.7K |
| 5 |
CAG
Csenge Advisory Group
Clearwater,
Florida
|
+$13.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFA
Farther Finance Advisors
San Francisco,
California
|
-$1 |
JAGX Hedge Fund Activity: Q4 2023 in Review
14 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q4 2023, worth a combined $191K — up 25% from $153K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new JAGX positions and 0 closed out — a net gain of 6 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $54.7K. The largest seller was Farther Finance Advisors, cutting an estimated $1.
- 14 institutional investors held Jaguar Health (JAGX) as of Q4 2023, up from 8 in Q3 2023.
- Funds reported $191K of Jaguar Health stock for Q4 2023, up 25% quarter-over-quarter.
- 6 funds opened new Jaguar Health positions in Q4 2023 and 0 closed out, a net change of +6 holders.
- The largest Jaguar Health buyer in Q4 2023 was Citadel Advisors, an estimated $54.7K added.
- The largest Jaguar Health seller in Q4 2023 was Farther Finance Advisors, an estimated $1 sold.
Based on aggregated 13F filings for Q4 2023.